On the other hand, IFNGR1, IRF6, and NFIL3 were present in the Basal subtype as well as before tumor formation in the cell line of the model, indicating that they could be good markers for Basal subtype breast cancer patients. This evidence concerns the gene IRF6 and breast carcinoma.